Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2020-07-07 Report Publication Anno…
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
results of the Extraordinary General Meeting of shareholders of the Company, Tuesday, July 7, 2020
Report Publication Announcement Classification · 95% confidence The document explicitly mentions 'Other Report or Announcement' under 'Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000'. Crucially, it states 'Attached hereto is a report on *07072020_6k_xtlbiopharma_isa.pdf*'. The presence of '6k' in the attached filename strongly suggests a reference to a Form 6-K, which is a report filed by foreign private issuers with the SEC. Since the document itself is an announcement stating that a report (likely a 6-K, which is analogous to a periodic report for foreign issuers) is attached, and given the short length (1864 chars), it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Because the document is an announcement about the publication of a specific report, RPA is the most precise fit based on the 'MENU VS MEAL' rule, although RNS is a strong secondary candidate for miscellaneous regulatory filings. Given the context of attaching a specific report, RPA is chosen.
2020-07-07 English
REPORT OF FOREIGN PRIVATE ISSUER
Board/Management Information Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It announces the results of an Extraordinary General Meeting (EGM) held on July 7, 2020, specifically the approval of employment terms for the CEO. The document is relatively short (3182 characters) and primarily serves as an announcement of the meeting results rather than a full report or detailed financial disclosure. It does not contain financial statements or detailed management discussion. The content aligns with announcements related to board or management changes, specifically employment terms of a senior executive. Therefore, the most appropriate classification is Board/Management Information (MANG).
2020-07-07 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document explicitly states it is an 'Immediate Report of Meeting' concerning the 'postponement of meeting' from 30/06/2020 to 07/07/2020. It details the agenda items (approving CEO terms) and voting procedures for an extraordinary meeting. This content—notices, agendas, and procedural updates related to a shareholder meeting—is characteristic of materials distributed to shareholders to inform them and solicit votes, which aligns best with the Proxy Solicitation & Information Statement (PSI) definition, or potentially an AGM-R if it were the final notice, but since it's a procedural update (postponement) related to a meeting, PSI is a strong fit, as it covers the solicitation/information aspect. However, given the context of Israeli filings often using specific forms for meeting notices, and the content being a direct notice about the meeting logistics and agenda, it is most closely related to the general process of soliciting shareholder input/information for a meeting. Since the document is a formal notice regarding the convening/postponement of a meeting and its agenda, it falls under the scope of materials provided to shareholders for voting purposes. If it were the final results, it would be DVA. If it were the presentation, it would be AGM-R. As a notice/update about the meeting logistics and agenda, PSI is the most appropriate fit among the choices, as it relates to soliciting information/votes. Alternatively, since it is a formal regulatory notice about a meeting, RNS could be considered, but PSI is more specific to the content type.
2020-06-30 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, XTL Biopharmaceuticals Ltd. It announces the postponement of an extraordinary shareholders' meeting due to lack of quorum and provides details about the rescheduled meeting date. The document is short (3082 characters) and primarily serves as an announcement rather than a detailed report. It does not contain financial statements or substantive financial data. The content is about a meeting postponement, which is a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-06-30 English
Financial results for the quarter ended March 31, 2020.
Earnings Release Classification · 98% confidence The document is explicitly titled "Form 6-K" and is filed by a "Foreign Private Issuer" with the SEC. The content is a press release announcing "FINANCIAL RESULTS" for the "FIRST QUARTER 2020" and includes selected consolidated statements of financial position and comprehensive income for the three months ended March 31, 2020. This structure—a press release summarizing quarterly financial performance—is characteristic of an Earnings Release (ER). Although it contains detailed financial tables, the primary format and context (a press release accompanying the filing) align best with the ER definition, which covers initial announcements of periodical financial results (key highlights only). It is not a comprehensive Annual Report (10-K) or a detailed Interim/Quarterly Report (IR), but rather the initial public announcement of those results. Q1 2020
2020-05-27 English
Financial results for the quarter ended March 31, 2020.
Report Publication Announcement Classification · 98% confidence The document explicitly states it is an 'Immediate Report' under Israeli regulations concerning a 'Foreign Corporation'. Crucially, it contains the line: 'Attached hereto is a report on*Financial results for the quarter ended March 31, 2020.*' and lists a PDF file name. This structure—a brief regulatory filing announcing the availability of a detailed financial report (for a quarter, not a full year)—fits the definition of a Report Publication Announcement (RPA). It is not the full financial report itself (which would be IR or 10-K), but the announcement of its publication. The document length is short (1892 chars), supporting the RPA classification over the full report classification.
2020-05-27 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.